It is noteworthy that these markers are not entirely breast-specific, as GATA3 can be expressed in certain renal neoplasms, neuroendocrine neoplasms, and urothelial carcinomas [29, 30]. This evidence concerns the gene GATA3 and neuroendocrine neoplasm.